JAK2V617F impairs lymphoid differentiation in myeloproliferative neoplasms

JAK2^V617F impairs lymphoid differentiation in myeloproliferative neoplasms

Leukemia. 2024 Nov;38(11):2487-2491. doi: 10.1038/s41375-024-02388-3. Epub 2024 Sep 7.

Daniel C Choi^{1

2}, Nassima Messali², Narasimha Rao Uda³, Ghaith Abu-Zeinah^{1

2}, Pouneh Kermani², Maria Mia Yabut², Heidi E L Lischer⁴, Franco Castillo Tokumori^{1

2}, Katie Erdos^{1

2}, Thomas Lehmann³, Marta Sobas⁵, Tata Nageswara Rao^{3

6}, Joseph M Scandura^{7

8}

¹ Richard T. Silver Myeloproliferative Neoplasms Center, Weill Cornell Medicine, New York, NY, USA.
² Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA.
³ Department of Oncology and Hematology, Medical Research Center, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
⁴ Interfaculty Bioinformatics Unit and Swiss Institute of Bioinformatics, University of Bern, Bern, Switzerland.
⁵ Department of Hematology, Blood Neoplasm and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland.
⁶ Institute for Pharmacology, University of Bern, Bern, Switzerland.
⁷ Richard T. Silver Myeloproliferative Neoplasms Center, Weill Cornell Medicine, New York, NY, USA. [email protected].
⁸ Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA. [email protected].

No abstract available